Regulation of glycogen phosphorylase and PDH during exercise in human skeletal muscle during hypoxia.
The present study examined the acute effects of hypoxia on the regulation of skeletal muscle metabolism at rest and during 15 min of submaximal exercise. Subjects exercised on two occasions for 15 min at 55% of their normoxic maximal oxygen uptake while breathing 11% O(2) (hypoxia) or room air (normoxia). Muscle biopsies were taken at rest and after 1 and 15 min of exercise. At rest, no effects on muscle metabolism were observed in response to hypoxia. In the 1st min of exercise, glycogenolysis was significantly greater in hypoxia compared with normoxia. This small difference in glycogenolysis was associated with a tendency toward a greater concentration of substrate, free P(i), in hypoxia compared with normoxia. Pyruvate dehydrogenase activity (PDH(a)) was lower in hypoxia at 1 min compared with normoxia, resulting in a reduced rate of pyruvate oxidation and a greater lactate accumulation. During the last 14 min of exercise, glycogenolysis was greater in hypoxia despite a lower mole fraction of phosphorylase a. The greater glycogenolytic rate was maintained posttransformationally through significantly higher free [AMP] and [P(i)]. At the end of exercise, PDH(a) was greater in hypoxia compared with normoxia, contributing to a greater rate of pyruvate oxidation. Because of the higher glycogenolytic rate in hypoxia, the rate of pyruvate production continued to exceed the rate of pyruvate oxidation, resulting in significant lactate accumulation in hypoxia compared with no further lactate accumulation in normoxia. Hence, the elevated lactate production associated with hypoxia at the same absolute workload could in part be explained by the effects of hypoxia on the activities of the rate-limiting enzymes, phosphorylase and PDH, which regulate the rates of pyruvate production and pyruvate oxidation, respectively.
Parolin
M L
ML
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Spriet
L L
LL
Hultman
E
E
Hollidge-Horvat
M G
MG
Jones
N L
NL
Heigenhauser
G J
GJ
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D002331:Carnitine / Q000378:metabolism; D003065:Coenzyme A / Q000378:metabolism; D004734:Energy Metabolism; D015444:Exercise / Q000502:physiology*; D006003:Glycogen / Q000378:metabolism; D006019:Glycolysis; D006321:Heart / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000097:blood / Q000201:enzymology* / Q000503:physiopathology; D019344:Lactic Acid / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000201:enzymology*; D010710:Phosphates / Q000378:metabolism; D006005:Phosphorylases / Q000378:metabolism*; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism*; D019289:Pyruvic Acid / Q000378:metabolism; D012119:Respiration
D010710:Phosphates; D011768:Pyruvate Dehydrogenase Complex; D019344:Lactic Acid; D019289:Pyruvic Acid; D000255:Adenosine Triphosphate; D006003:Glycogen; D006005:Phosphorylases; D002331:Carnitine; D003065:Coenzyme A